Smith & Nephew bets on technology that ‘sees through the skin’
The Telegraph have published an article announcing the £2.5…
OCT in the Clinic!
We are delighted to announce that VivoSight OCT…
Michelson Diagnostics closes £2.5 million First Tranche of £4.0 million
Michelson Diagnostics, the UK based medical device company…
Michelson Diagnostics, the UK based medical device company…
Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis
Michelson Diagnostics, the UK based medical device company focused…
VivoSight sessions at EADV Conference in Amsterdam
Michelson Diagnostics are delighted to announce 2 fabulous…
Michelson to exhibit at EADV Conference 8-12 October
We are looking forward to exhibiting at the…
VivoSight OCT scanner, images and data to be presented at ADO Hautkrebs 2014, Frankfurt Am Main, 11-13th September 2014
Professor Julia Welzel, Chief Physician at Dept. of…
Michelson Diagnostics to present at Fortbildungswoche, Munich
Michelson Diagnostics, the UK based medical device company…
New study on non-invasive diagnosis of non-melanoma skin cancer with Melanoma Institute of Australia
Michelson Diagnostics, the UK based medical device company…